Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1566044 · YARW

Yarrow Bioscience, Inc.

Filing with the SEC SEC-reporting company New Haven, CT Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Mar 11, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Change in controlOn Jul 28, 2026 the company reported a change in control (Item 5.01).
  • Stockholders’ deficitAt the end of 2025 stockholders’ equity was negative: −$71M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $26.5M for the year (2024: −$39.8M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$570K$501K
Net income (loss)−$26.5M−$39.8M
Total assets$100M$66.9M
Total liabilities$71.5M$14.8M
Stockholders’ equity−$71M$52.1M
Cash and equivalents$100M$19.9M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Yarrow Bioscience, Inc.
Formerly: VYNE Therapeutics Inc.
CIK
0001566044
Tickers
YARW
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
New Haven, Connecticut
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Aug 5, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01 · filed Jul 28, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01 · filed Jul 28, 2026 · filing
  • Results announced
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01 · filed Jul 28, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01 · filed Jul 28, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 15, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Mar 11, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 27, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 9.01 · filed Dec 17, 2025 · filing
  • Change in control
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 9.01 · filed Dec 17, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Aug 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Aug 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Jul 30, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 6, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 6, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Dec 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 14, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 1, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 29, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 3, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Dec 13, 2023 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Nov 16, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 13, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 13, 2023 · filing
  • Results announced
    Form 8-K · items 1.01, 1.02, 2.02, 3.02, 5.08, 7.01, 8.01, 9.01 · filed Oct 30, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02 · filed May 11, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 11, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 9, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 5.07, 7.01, 8.01 · filed Jan 12, 2023 · filing